Skip to main content
Caplight Logo









EverBridge Group

EverBridge Group

Private
ShanghaiHealthcare & Life Scienceshttps://www.everbridgemed.com/

Last Round

Series A

Mar 25, 2025

Total Funding Raised

$138M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

EverBridge Group is a medical technology company that develops and manufactures medical devices for peripheral vascular, neuroscience, and interventional oncology applications.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

interventional medical devicesminimally invasive surgerymedtechperipheral vascular interventionneuroscience interventiononcology diagnosisradiofrequency ablationRFAmedical cathetersstent technologyrobot-assisted surgerysurgical roboticsmedical imaging analysisclinical data miningvascular health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EverBridge Group Comparables

Compare EverBridge Group with similar companies based on industry and business-model similarity.

EverBridge Group comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CardioCycle Medical Technology (Suzhou) Co., Ltd.
83%
Shunmei Medical Co., Ltd.
80%
Kossel Medtech (Suzhou) Co., Ltd.
79%

EverBridge Group Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 25, 2025

Key People

Founding team and executive leadership

Jay Wang

Chief Executive Officer

Executive Team

EverBridge Group Investors

Notable investors and investment history

EverBridge Group investors
InvestorRounds
CBC GroupSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 38% MoM.

  • Jun 24, 2026

    Monthly visitors increased 91% MoM.

EverBridge Group Filings

Explore SEC and related filing metadata, where available.

EverBridge Group filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about EverBridge Group's valuation, stock price, and market status.

Is EverBridge Group a public or private company?

EverBridge Group is a private company.

What is the current stock price of EverBridge Group?

EverBridge Group is a private company, so its shares have no public market price. Caplight tracks EverBridge Group's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is EverBridge Group worth (valuation)?

Valuation information for EverBridge Group is not publicly available.

Can I buy EverBridge Group stock?

EverBridge Group shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was EverBridge Group's last funding round?

EverBridge Group's most recent funding round was Series A on March 25, 2025.

Who are the main investors in EverBridge Group?

Key investors in EverBridge Group include CBC Group.

Will EverBridge Group IPO soon?

No public IPO plans have been announced for EverBridge Group.

How can I track EverBridge Group secondary market activity?

Caplight tracks bids, offers, and trades in EverBridge Group's shares on secondary markets.

Firmographic Details

HeadquartersShanghai
Employee Range16
Year Founded2021
Last FundingMar 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?